In contrast, GPC5 protein expression levels examined by immunohistochemistry, are reduced in prostate cancer tissues compared with normal tissues, indicating that GPC5 could represent an additional prostate cancer biomarker [10]. The gene discussed is GPC5; the disease is prostate carcinoma.